Which patients with prostatic carcinoma require a staging bone scan?
| Autor: | N.J. Bird, G.A. Maguire, P.M. Kemp |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Stage classification
Male medicine.medical_specialty Urology Bone Neoplasms Newly diagnosed Bone scans Scintigraphy Prostate Predictive Value of Tests medicine Carcinoma Humans Radionuclide imaging Radionuclide Imaging Aged Neoplasm Staging Retrospective Studies Aged 80 and over medicine.diagnostic_test business.industry Patient Selection Prostatic Neoplasms Middle Aged Prostate-Specific Antigen medicine.disease Surgery Prostate-specific antigen medicine.anatomical_structure Radiology business |
| Zdroj: | British journal of urology. 79(4) |
| ISSN: | 0007-1331 |
| Popis: | Objective To determine whether the level of prostate-specific antigen (PSA) can be used to decide which patients with newly diagnosed prostatic carcinoma require a staging bone scan. Patients and methods Of patients referred during an 18-month period for a staging bone scan, 98 (median age 72 years, range 52–89) had had their serum PSA level determined within 4 weeks of the bone scan and were assessed retrospectively for the presence of bony metastases. Results Of the 98 patients, 26 who had bone scans showing bony metastases had a PSA level >40 ng/mL. Reviewing the other published studies showed that in those newly diagnosed patients with a PSA level of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text